André T.
- Country
- Portugal
- Department
- Genetic
Research Overview
- Efficacy and Safety Evaluation of Setrusumab in Osteogenesis Imperfecta: A Randomized Phase 2/3 Study with Dose-Evaluation and Placebo-Controlled Phases
- Efficacy and Safety Evaluation of Fidrisertib (IPN60130) in Fibrodysplasia Ossificans Progressiva: A Phase 2 Randomized Controlled Trial
- Efficacy and Safety Evaluation of INCB000928 in Fibrodysplasia Ossificans Progressiva: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 4 of 18 partner sites.
Specializations
Rare Bone Disorders
This investigator specializes in treating severe bone disorders, with particular emphasis on Fibrodysplasia Ossificans Progressiva (FOP) and Osteogenesis Imperfecta (OI). Their clinical focus includes innovative therapeutic approaches for these challenging conditions.
- Heterotopic Ossification Management
- Bone Formation Disorders
- Progressive Skeletal Conditions
The investigator works extensively with both pediatric and adult patient populations affected by rare bone disorders.
Therapeutic Development
The investigator's work centers on evaluating novel therapeutic agents for rare bone conditions, including monotherapy treatments and comparative studies with established protocols.
- Bone Density Enhancement
- Fracture Prevention
- Disease Progression Control
Their clinical interests encompass the assessment of therapeutic efficacy in skeletal disorders using advanced imaging techniques.
Clinical Assessment
The investigator employs sophisticated diagnostic approaches including whole body computed tomography for monitoring disease progression and treatment outcomes in bone disorders.
- Advanced Imaging Techniques
- Safety Monitoring
- Treatment Response Assessment
Their work includes comprehensive evaluation of treatment safety and efficacy in rare bone conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.